Annual Working Capital
$155.16 M
-$89.52 M-36.59%
31 December 2023
Summary:
Poseida Therapeutics annual working capital is currently $155.16 million, with the most recent change of -$89.52 million (-36.59%) on 31 December 2023. During the last 3 years, it has fallen by -$128.81 million (-45.36%). PSTX annual working capital is now -45.36% below its all-time high of $283.97 million, reached on 31 December 2020.PSTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$172.44 M
+$20.53 M+13.52%
30 September 2024
Summary:
Poseida Therapeutics quarterly working capital is currently $172.44 million, with the most recent change of +$20.53 million (+13.52%) on 30 September 2024. Over the past year, it has dropped by -$3.26 million (-1.85%). PSTX quarterly working capital is now -45.69% below its all-time high of $317.51 million, reached on 30 September 2020.PSTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.6% | -1.9% |
| 3 y3 years | -45.4% | -0.3% |
| 5 y5 years | +691.0% | - |
PSTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.4% | at low | -37.6% | +59.6% |
| 5 y | 5 years | -45.4% | +691.0% | -45.7% | +150.8% |
| alltime | all time | -45.4% | +1708.2% | -45.7% | +150.8% |
Poseida Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $172.44 M(+13.5%) |
| June 2024 | - | $151.90 M(+15.1%) |
| Mar 2024 | - | $131.97 M(-14.9%) |
| Dec 2023 | $155.16 M(-36.6%) | $155.16 M(-11.7%) |
| Sept 2023 | - | $175.69 M(-2.6%) |
| June 2023 | - | $180.31 M(-15.0%) |
| Mar 2023 | - | $212.01 M(-13.4%) |
| Dec 2022 | $244.68 M(+43.5%) | $244.68 M(-11.4%) |
| Sept 2022 | - | $276.16 M(+155.6%) |
| June 2022 | - | $108.03 M(-26.3%) |
| Mar 2022 | - | $146.59 M(-14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $170.54 M(-39.9%) | $170.54 M(-1.4%) |
| Sept 2021 | - | $173.00 M(-17.0%) |
| June 2021 | - | $208.37 M(-15.4%) |
| Mar 2021 | - | $246.21 M(-13.3%) |
| Dec 2020 | $283.97 M(+169.6%) | $283.97 M(-10.6%) |
| Sept 2020 | - | $317.51 M(+120.1%) |
| June 2020 | - | $144.25 M(+109.8%) |
| Mar 2020 | - | $68.74 M(-34.7%) |
| Dec 2019 | $105.32 M(+437.0%) | $105.32 M |
| Dec 2018 | $19.61 M(+128.6%) | - |
| Dec 2017 | $8.58 M | - |
FAQ
- What is Poseida Therapeutics annual working capital?
- What is the all time high annual working capital for Poseida Therapeutics?
- What is Poseida Therapeutics annual working capital year-on-year change?
- What is Poseida Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly working capital year-on-year change?
What is Poseida Therapeutics annual working capital?
The current annual working capital of PSTX is $155.16 M
What is the all time high annual working capital for Poseida Therapeutics?
Poseida Therapeutics all-time high annual working capital is $283.97 M
What is Poseida Therapeutics annual working capital year-on-year change?
Over the past year, PSTX annual working capital has changed by -$89.52 M (-36.59%)
What is Poseida Therapeutics quarterly working capital?
The current quarterly working capital of PSTX is $172.44 M
What is the all time high quarterly working capital for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly working capital is $317.51 M
What is Poseida Therapeutics quarterly working capital year-on-year change?
Over the past year, PSTX quarterly working capital has changed by -$3.26 M (-1.85%)